戻る Agenda
Session 2: The Role of the Labeling Group in a Changing Regulatory Affairs Environment
Session Chair(s)
Gerrit Nijveldt, MSc
Global Labeling Consultant
Opus Regulatory Inc., United States
Speaker(s)
Panelist
Theresa Brunone, MLS, MS
GlaxoSmithKline, United States
Head-Labelling Compliance and Implementation, Global Labeling
Panelist
Dora W Cohen, MSc
PRA HS, United States
Director, Global Labeling
Panelist
Mark Collins, PhD, MBA
Opus Regulatory, United States
Principal Consultant
Panelist
Michelle L. Halliez
SANOFI, United States
Associate Vice President of Global Labeling
Panelist
Julie P. Retzinger, MBA, RN
Astellas Pharma Inc., United States
Senior Director - Global Labeling and CCDS